These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18516022)

  • 21. Sustained response after reduced-intensity conditioning allogeneic stem cell transplantation for patients with relapsed peripheral T-cell non-Hodgkin lymphoma.
    de Lavallade H; Cassier PA; Bouabdallah R; El-Cheikh J; Faucher C; Fürst S; Coso D; Sainty D; Arnoulet C; Gastaut JA; Chetaille B; Xerri L; Blaise D; Mohty M
    Br J Haematol; 2008 Sep; 142(5):848-50. PubMed ID: 18631344
    [No Abstract]   [Full Text] [Related]  

  • 22. Hematopoietic stem cell therapy for malignant diseases.
    Shapira MY; Hai AA; Tsirigotis P; Resnick IB; Or R; Slavin S
    Ann Med; 2007; 39(6):465-73. PubMed ID: 17852026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced intensity conditioning and hematopoietic stem cell transplantation in pediatric nonmalignant disease: a new therapeutic paradigm.
    Abikoff CM; Cairo MS
    J Pediatr; 2014 May; 164(5):952-953.e2. PubMed ID: 24742647
    [No Abstract]   [Full Text] [Related]  

  • 24. Unrelated bone marrow transplantation using a reduced intensity-conditioning regimen in leukocyte adhesion deficiency.
    Takahashi D; Nagatoshi Y; Saito Y; Inagaki J; Nagayama J; Shinkoda Y; Fujita K; Okamura J
    Bone Marrow Transplant; 2006 Apr; 37(8):807-8. PubMed ID: 16532019
    [No Abstract]   [Full Text] [Related]  

  • 25. Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD.
    Novitzky N; Thomas V; du Toit C; McDonald A
    Bone Marrow Transplant; 2009 May; 43(10):779-85. PubMed ID: 19079315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation: a clinical review.
    Pollack SM; O'Connor TP; Hashash J; Tabbara IA
    Am J Clin Oncol; 2009 Dec; 32(6):618-28. PubMed ID: 19593085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of tolerance in organ recipients by hematopoietic stem cell transplantation.
    Ophir E; Reisner Y
    Int Immunopharmacol; 2009 Jun; 9(6):694-700. PubMed ID: 19150657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corticosteroids in the prevention of graft-vs-host disease after allogeneic myeloablative stem cell transplantation: a systematic review and meta-analysis.
    Quellmann S; Schwarzer G; Hübel K; Engert A; Bohlius J
    Leukemia; 2008 Sep; 22(9):1801-3. PubMed ID: 18449206
    [No Abstract]   [Full Text] [Related]  

  • 29. Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome.
    Gluckman E; Wagner JE
    Bone Marrow Transplant; 2008 Jan; 41(2):127-32. PubMed ID: 18084332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen.
    Brazzola P; Duval M; Fournet JC; Gauvin F; Dalle JH; Champagne J; Champagne MA
    Bone Marrow Transplant; 2005 Dec; 36(12):1103-5; author reply 1105. PubMed ID: 16205731
    [No Abstract]   [Full Text] [Related]  

  • 33. [Current status and issues in hematopoietic stem cell transplantation].
    Harada M
    Fukuoka Igaku Zasshi; 2007 Feb; 98(2):35-47. PubMed ID: 17396570
    [No Abstract]   [Full Text] [Related]  

  • 34. Age-dependent pharmacokinetic profile of single daily dose i.v. busulfan in children undergoing reduced-intensity conditioning stem cell transplant.
    Tse WT; Duerst R; Schneiderman J; Chaudhury S; Jacobsohn D; Kletzel M
    Bone Marrow Transplant; 2009 Aug; 44(3):145-56. PubMed ID: 19182832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major.
    Bernardo ME; Zecca M; Piras E; Vacca A; Giorgiani G; Cugno C; Caocci G; Comoli P; Mastronuzzi A; Merli P; La Nasa G; Locatelli F
    Br J Haematol; 2008 Nov; 143(4):548-51. PubMed ID: 18986389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transplants in Adult ALL--? Allo for everyone.
    Goldstone AH
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):7-10. PubMed ID: 19147069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innovations in preparative regimens for autologous hematopoietic cell transplantation.
    Appelbaum FR
    Biol Blood Marrow Transplant; 2005 Feb; 11(2 Suppl 2):40-2. PubMed ID: 15682175
    [No Abstract]   [Full Text] [Related]  

  • 38. Maximum supportive care, standard conditioning and allogeneic stem cell transplantation for elderly patients with acute myelogenous leukemia.
    Petersen FB; Ford CD
    Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S7-9. PubMed ID: 19561415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies.
    Rocha V; Mohty M; Gluckman E; Rio B; ; ;
    Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S31-4. PubMed ID: 19561411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis.
    Gupta V; Kröger N; Aschan J; Xu W; Leber B; Dalley C; Sabloff M; Lipton JH; Messner H; Brune M
    Bone Marrow Transplant; 2009 Sep; 44(5):317-20. PubMed ID: 19234505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.